Musculoskeletal Research Unit, Department of Academic Orthopaedics, University of Bristol, Lower Level AOC, Southmead Hospital, Westbury-on-Trym, United Kingdom.
J Arthroplasty. 2013 May;28(5):842-8. doi: 10.1016/j.arth.2013.01.007. Epub 2013 Mar 13.
Resurfacing (RA) and total hip arthroplasty (THA) are options in the treatment of debilitating hip pathology. 381 patients that had undergone arthroplasty with a BHR RA, ASR RA, metal-on-metal (MoM) THA or ceramic-on-ceramic (CoC) THA were reviewed for satisfaction, function, health and survivorship at a median follow up of 50 months. Significantly lower survivorship for revision and reoperation was observed in the ASR group. The BHR and CoC demonstrated better outcome scores than the ASR (OHS and SAPS) and the BHR better scores than the MoM (OHS and SF12 PCS). In the short to medium term, survivorship and outcomes for the best performing RA (BHR) and THA (CoC) were comparable. There was a non-significant trend towards poorer outcome scores in the MoM THA group.
表面置换术（RA）和全髋关节置换术（THA）是治疗致残性髋关节疾病的选择。对接受 BHR RA、ASR RA、金属对金属（MoM）THA 或陶瓷对陶瓷（CoC）THA 关节置换术的 381 例患者进行了满意度、功能、健康和存活率的回顾性分析，中位随访时间为 50 个月。在 ASR 组中，观察到翻修和再次手术的存活率明显较低。BHR 和 CoC 的 OHS 和 SAPS 评分均优于 ASR，BHR 的 OHS 和 SF12 PCS 评分均优于 MoM。在短期至中期，表现最佳的 RA（BHR）和 THA（CoC）的存活率和结果相当。MoM THA 组的结果评分有较差的非显著趋势。
